Wu, Qin http://orcid.org/0000-0002-5365-7482
Nie, David Y.
Ba-alawi, Wail
Ji, YiShuai
Zhang, ZiWen
Cruickshank, Jennifer
Haight, Jillian
Ciamponi, Felipe E.
Chen, Jocelyn http://orcid.org/0000-0002-7198-6386
Duan, Shili
Shen, Yudao
Liu, Jing http://orcid.org/0000-0003-4740-243X
Marhon, Sajid A. http://orcid.org/0000-0002-1046-9852
Mehdipour, Parinaz
Szewczyk, Magdalena M.
Dogan-Artun, Nergiz
Chen, WenJun
Zhang, Lan Xin http://orcid.org/0000-0002-5918-8082
Deblois, Genevieve
Prinos, Panagiotis http://orcid.org/0000-0001-8785-7856
Massirer, Katlin B.
Barsyte-Lovejoy, Dalia http://orcid.org/0000-0002-6560-9621
Jin, Jian http://orcid.org/0000-0002-2387-3862
De Carvalho, Daniel D.
Haibe-Kains, Benjamin
Wang, XiaoJia
Cescon, David W.
Lupien, Mathieu http://orcid.org/0000-0003-0929-9478
Arrowsmith, Cheryl H. http://orcid.org/0000-0002-4971-3250
Article History
Received: 22 June 2021
Accepted: 27 March 2022
First Online: 16 May 2022
Competing interests
: J.J. is a cofounder, consultant, shareholder and scientific advisory board member in Cullgen, Inc. J.J. is also a consultant at Accent Therapeutics, Inc., and EpiCypher, Inc. The J.J. lab received research funds from Cullinan Oncology, Inc., Celgene Corporation, Cullgen, Inc., and Levo Therapeutics, Inc. D.D.D.C. is a cofounder, employee and shareholder at DNAMx, Inc. D.D.D.C. received funding unrelated to this project from Pfizer and Nektar Therapeutics. All other authors declare no competing interests.